RAP
Click for more information
0.00% 20.5¢ resapp health limited

Ann: Coviu and ResApp Complete Initial ResAppDx-EU Integration, page-4

  1. Jackpot518
    651 Posts.
    lightbulb Created with Sketch. 17
    clock Created with Sketch.
    30/03/20
    10:06
    Post #: 43769119
    ResApp and Coviu have signed a binding commercial terms sheet and have agreed upon a per
    test fee for the use of ResAppDx-EU on Coviu’s telehealth platform. The per test fee received by
    ResApp is within the previously targeted range of $5-10 per test.

    RAP Price at posting: 14.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 34  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

VUL Vulcan smashes through $5/sh resistance level as final funding stage live
right-arrow Created with Sketch.
FRE Firebrick Pharma sees substantial holder up stake to 12% in placement
right-arrow Created with Sketch.
M2R Miramar upgrades target within WA's Gidji, suggests extension to Northern Star's 8 Mile Dam
right-arrow Created with Sketch.
TMB Tambourah gets state govt grant for drilling at namesake gold project in WA
right-arrow Created with Sketch.
SBW The home PC changed retail stores forever. Shekel Brainweigh can do it again
right-arrow Created with Sketch.
BRX Sampling in Argentina points the way to a base metals porphyry for Belararox
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.